Skip to content

Understanding the Causes and Symptoms of Indigestion (Amlapitta) and the Relief Provided by Jeerakadya Ghrita

Assessment of Annavaha Srotodushti Hetu and Lakshana in Amlapitta and Upashayatmak effect of Jeerakadya Ghrita: A Single Arm Open Label Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097477
Enrollment
36
Registered
2025-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed Amlapitta patients (based on Ayurvedic signs and symptoms like Avipaka, Klama, Utklesha, Amla-tikta udgara, Gaurava, Hrit-kantha daaha, Aruchi) attending O.P.D of AIIA 2.Willing to provide informed consent and follow study protocol. 3.Patients with deranged Annavaha srotas functions as assessed through Annavaha Srotodushti Hetu and Lakshan Questionnaire.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2.History of infections or GI conditions (e.g., hepatitis, HIV, peptic ulcer, esophageal varices). 3.Substance abuse (alcohol, tobacco, or drugs). 4.Ongoing hormonal or psychosomatic treatment. 5.Patients with poor dental health. 6.Patients with controlled Diabetes mellitus, Hypertension, cardiovascular, neurological disorders, malignancies, hemorrhoids, thyroid disorders.

Design outcomes

Primary

MeasureTime frame
1.Improvement in clinical symptoms of Amlapitta before and after administration of Jeerakadya Ghrita. 2.Change in salivary pH from baseline to post-treatment, indicating the effect of therapy.Timepoint: 1.Improvement in clinical symptoms of Amlapitta before and after administration of Jeerakadya Ghrita.

Secondary

MeasureTime frame
Change in pepsinogen levels at 30th day of intervention to assess symptom reliefTimepoint: 0th & 30th day

Countries

India

Contacts

Public ContactDr Pakhrani Priyanka Mohanlal

All India Institute of Ayurveda

drvivek91@gmail.com9416608598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026